Healthcare Webinars

The 4 Levels of FASD Prevention. Date & Time: Dec 5, 2023 07:00 PM in Universal Time UTC.

Global Perspectives Film Series: Ask the Sexpert

The American Medical Association (AMA) and Manatt Health will share a year-end snapshot of key telehealth policy trends, including a summary of 2023 legislative activity with specific state examples.

In this informative webinar, explore the challenges of global feasibility and gain insights into strategies for successful study start-ups, including protocol optimization, geostrategy and site selection. Global feasibility is the linchpin of successful study start-ups, but it is not a cut-and-dry process. Successful feasibility goes beyond choosing the right countries and the right sites with proximity to the target patient population. It also requires the careful balance of competing organizational priorities from different stakeholders with the potential risks that each presents. How do clinical experts find a compromise between stakeholders when evaluating protocol optimization, geostrategy, site selection and delivery performance? In this webinar, global feasibility and clinical operations experts from Regeneron and Parexel will share their insights, best practices and case studies on global feasibility strategies.

Join us for an informative webinar on creating induced pluripotent stem cells (iPSCs) which sheds light on the strengths of the mRNA technique compared to other methods.Discover the new Miltenyi Biotec mRNA reprogramming workflow and its myriad of benefits including enhanced efficiency, safety, and reproducibility in a streamlined process that ensures high-quality iPSCs.Hannah Johannsen and Parivash Nouri (Miltenyi Biotec) will provide a comprehensive overview of the entire reprogramming workflow — from fibroblast collection to iPSC generation, isolation, and quality control.Sebastian Diecke (Max Delbrück Center, Berlin) will showcase outcomes achieved in his lab through the application of the technique.Understand each step within the reprogramming workflowLearn how to optimize your reprogramming experimentsGain practical insights into reprogramming or iPSC generation from first-hand experience

In this informative webinar, discover strategies for patient engagement and digital therapeutics relating to the management of social determinants of health in cardiometabolic diseases and recent Food and Drug Administration (FDA) guidance on the future of Lupus research.

Empirical and theoretical evidence shows that mass dog vaccination interrupts the transmission cycle and if sustained can eliminate dog-mediated rabies. But constraints and barriers can prevent vaccination campaigns from reaching target or sufficient coverage of the dog population. There are resources and tools available to help overcome many of these constraints and barriers, but are they reaching the right audiences? And are any constraints or barriers left unaddressed? Join this webinar to learn more about addressing these barriers in order to scale up dog vaccination campaigns to effectively prevent and control rabies.

Get ready for the BRAINTEASER webinar where we'll delve into the experiences of women living with MS and clinical experts

Discover a groundbreaking webinar delving into the future of dry eye clinical trial design and execution for emerging treatments. A highly prevalent multi-factorial disease affecting millions of patients, dry eye disease can still be a challenging condition to treat. This webinar will discuss ways to optimize dry eye clinical trial designs and execution.

Discover a groundbreaking webinar delving into how personalizing digital biomarkers and health protocols is crucial for harnessing the full potential of digital health technologies. Much of the discussion of personalized healthcare has involved using genomic information to adapt treatment. By providing a wealth of information about the individual patient, digital health technologies (DHTs) provide a similar opportunity. In fact, we believe that personalizing digital biomarkers and digital health protocols will be necessary to enable the effective use of digital health technologies. Recent work in the field has indicated huge benefits, including reducing the required sample size in a clinical trial by an order of magnitude and identifying the onset of illness before the patient is even aware of it. However, this approach will require a paradigm shift in how data are analyzed, how clinical endpoints are formulated, and how clinicians manage patients. New approaches will involve techniques from artificial intelligence (AI), machine learning, and statistical process control. Although the featured speakers will touch upon science and analytics, their focus will be on the practical implications of this paradigm shift for managers and executives — both in clinical research and in healthcare delivery. They will provide practical advice and lessons learned for managing these changes.